Drug Shortage Report for ADACEL-POLIO

Last updated on 2018-02-11 History
Report ID 1181
Drug Identification Number 02352044
Brand name ADACEL-POLIO
Common or Proper name Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed Combined with Inactivated Poliomyelitis Vaccine
Company Name SANOFI PASTEUR LIMITED
Market Status MARKETED
Active Ingredient(s) INACTIVATED POLIOMYELITIS VACCINE PERTACTIN FILAMENTOUS HAEMAGGLUTININ PERTUSSIS TOXOID FIMBRIAE TYPES 2 AND 3 INACTIVATED POLIOMYELITIS VACCINE INACTIVATED POLIOMYELITIS VACCINE TETANUS TOXOID DIPHTHERIA TOXOID
Strength(s) 8UNIT 3MCG 5MCG 2.5MCG 5MCG 32UNIT 40UNIT 5LF 2LF
Dosage form(s) SUSPENSION
Route of administration INTRAMUSCULAR
Packaging size 10 x 0.5 mL syringes / 10 seringues de 0,5 mL
ATC code J07CA
ATC description BACTERIAL AND VIRAL VACCINES, COMBINED
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2016-06-22
Actual start date 2016-06-22
Estimated end date Unknown
Actual end date 2018-02-01
Shortage status Resolved
Updated date 2018-02-11
Company comments The supply has been restored on February 01, 2018.
Health Canada comments
Tier 3 Status No
Contact Address 1755 STEELES AVENUE WEST
TORONTO, ONTARIO
CANADA M2R 3T4
Company contact information Customer Service/Service à la clientèle: 1-800-268-4171 Vaccine Information Service/Service d'information sur les vaccins: 416-667-2611 or 1-888-621-1146

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2018-02-11 French Compare
v12 2018-02-11 English Compare
v11 2017-03-13 French Compare
v10 2017-03-13 English Compare
v9 2017-03-13 French Compare
v8 2017-03-13 French Compare
v7 2017-03-13 English Compare
v6 2017-03-13 French Compare
v5 2017-03-13 French Compare
v4 2017-03-13 English Compare
v3 2017-03-13 French Compare
v2 2017-03-13 French Compare
v1 2017-03-13 English Compare

Showing 1 to 13 of 13